British pharmaceutical manufacturer moves to Denmark: We'll find the best workforce here
Denmark's position in the world market for peptide-based pharmaceutical development now causes a British biotech firm to relocate its entire management and development lab to the country. The goal is effective growth, and the firm has already made a deal with a top-ten pharma company.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.